tiprankstipranks
Trending News
More News >
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Revenue

Compare
392 Followers

Gain Therapeutics Revenue

Gain Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Gain Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
23
Market Cap
$148.46M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
-55.18K
Dec 31, 2023
55.18K-77.46K+41.60%
Dec 31, 2022
132.64K-1.29K+99.04%
Dec 31, 2021
133.93K105.05K+463.74%
Dec 31, 2020
28.88K-12.42K+69.93%
Dec 31, 2019
41.30K20.69K+200.41%
Dec 31, 2018
20.61K